Growth Metrics

Cytek Biosciences (CTKB) Non Operating Income (2020 - 2026)

Cytek Biosciences filings provide 6 years of Non Operating Income readings, the most recent being $258000.0 for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 96.48% to $258000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 33.4% decrease, with the full-year FY2025 number at $8.8 million, down 40.63% from a year prior.
  • Non Operating Income hit $258000.0 in Q4 2025 for Cytek Biosciences, down from $1.3 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.5 million in Q4 2023 to a low of -$946000.0 in Q1 2022.
  • Median Non Operating Income over the past 5 years was $1.5 million (2023), compared with a mean of $1.7 million.
  • Biggest five-year swings in Non Operating Income: crashed 350.14% in 2021 and later soared 6184.75% in 2025.
  • Cytek Biosciences' Non Operating Income stood at -$873000.0 in 2021, then skyrocketed by 327.26% to $2.0 million in 2022, then surged by 279.84% to $7.5 million in 2023, then decreased by 2.64% to $7.3 million in 2024, then plummeted by 96.48% to $258000.0 in 2025.
  • The last three reported values for Non Operating Income were $258000.0 (Q4 2025), $1.3 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.